A new trading day began on Friday, with Icad Inc (NASDAQ: ICAD) stock price down -8.03% from the previous day of trading, before settling in for the closing price of $3.61. ICAD’s price has ranged from $1.18 to $3.78 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -11.41%. Meanwhile, its annual earnings per share averaged 18.19%. With a float of $25.05 million, this company’s outstanding shares have now reached $26.35 million.
Let’s determine the extent of company efficiency that accounts for 69 employees. In terms of profitability, gross margin is 85.32%, operating margin of -32.31%, and the pretax margin is -27.87%.
Icad Inc (ICAD) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Icad Inc is 5.63%, while institutional ownership is 21.81%.
Icad Inc (ICAD) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 18.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 17.98% during the next five years compared to 11.68% growth over the previous five years of trading.
Icad Inc (NASDAQ: ICAD) Trading Performance Indicators
Here are Icad Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.13, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.22 in one year’s time.
Technical Analysis of Icad Inc (ICAD)
Looking closely at Icad Inc (NASDAQ: ICAD), its last 5-days average volume was 0.53 million, which is a drop from its year-to-date volume of 0.62 million. As of the previous 9 days, the stock’s Stochastic %D was 66.54%. Additionally, its Average True Range was 0.35.
During the past 100 days, Icad Inc’s (ICAD) raw stochastic average was set at 81.19%, which indicates a significant increase from 50.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 140.42% in the past 14 days, which was higher than the 103.03% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.36, while its 200-day Moving Average is $1.75. However, in the short run, Icad Inc’s stock first resistance to watch stands at $3.60. Second resistance stands at $3.87. The third major resistance level sits at $4.05. If the price goes on to break the first support level at $3.15, it is likely to go to the next support level at $2.97. Now, if the price goes above the second support level, the third support stands at $2.70.
Icad Inc (NASDAQ: ICAD) Key Stats
With a market capitalization of 88.11 million, the company has a total of 26,540K Shares Outstanding. Currently, annual sales are 17,320 K while annual income is -4,850 K. The company’s previous quarter sales were 4,220 K while its latest quarter income was -1,800 K.
